Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Verastem (VSTM) EBT (2018 - 2025)

Verastem (VSTM) has 8 years of EBT data on record, last reported at -$40.6 million in Q4 2025.

  • For Q4 2025, EBT fell 27.79% year-over-year to -$40.6 million; the TTM value through Dec 2025 reached -$166.9 million, down 44.66%, while the annual FY2025 figure was -$209.5 million, 60.57% down from the prior year.
  • EBT reached -$40.6 million in Q4 2025 per VSTM's latest filing, down from -$39.7 million in the prior quarter.
  • Across five years, EBT topped out at -$15.0 million in Q1 2021 and bottomed at -$43.4 million in Q1 2025.
  • Average EBT over 5 years is -$25.9 million, with a median of -$21.1 million recorded in 2022.
  • The widest YoY moves for EBT: up 60.43% in 2021, down 273.44% in 2021.
  • A 5-year view of EBT shows it stood at -$16.5 million in 2021, then fell by 1.94% to -$16.8 million in 2022, then crashed by 80.88% to -$30.4 million in 2023, then dropped by 4.53% to -$31.8 million in 2024, then fell by 27.79% to -$40.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for EBT were -$40.6 million in Q4 2025, -$39.7 million in Q3 2025, and -$43.2 million in Q2 2025.